Skip to main content
PMC home page
Oncotarget logoLink to Oncotarget
. 2019 Apr 2;10(26):2576. doi: 10.18632/oncotarget.26855

Correction: Monitoring EGFR-T790M mutation in serum/plasma for prediction of response to third-generation EGFR inhibitors in patients with lung cancer

Teresa Morán 1, Eudald Felip 1, Joaquim Bosch-Barrera 2, Itziar de Aguirre 3, Jose Luis Ramirez 3, Carles Mesia 4, Enric Carcereny 1, Diana Roa 2, Elia Sais 2, Yolanda García 5, Remei Blanco 6, Silvia Sanchez 7, Claudia Rosa Villacorta 7, Cristina Queralt 3, Jose María Velarde 8, Rafael Rosell 3
PMCID: PMC6493461  PMID: 31069018

This article has been corrected: The correct affiliation information is given below:

1 Medical Oncology Department, Catalan Institute of Oncology - Badalona, Hospital Universitari Germans Trias i Pujol, Badalona, Department of Medicine, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain

Original article: Oncotarget. 2018; 9:27074-27086. https://doi.org/10.18632/oncotarget.25478

Articles from Oncotarget are provided here courtesy of Impact Journals, LLC

RESOURCES